Metformin attenuates HSV-1-induced neuropathic pain by restoring Sirt3-mediated mitophagy

Read full text Summarise with VIRAT
Authors: Yuanyuan Fang, Mengqiu Deng, Kesheng Huang, Honghao Song, Yan Chu, Huawei Wei, Dashuang Chen, Yutong Yang, Chaofeng Han, Hongbin Yuan
Cited by: 0
References: 67

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Varicella-zoster virus reactivation causes neuroinflammation and post-herpetic neuralgia (PHN), in which the mechanism needs to be further explored. Given that Herpes simplex virus type 1 (HSV-1) infection induces a similar neuropathological process, a corresponding model was established for this study. Here we reported that Sirt3 expression decreased in spinal dorsal horn and microglia upon HSV-1 infection-induced neuropathic pain model, which was accompanied by increased mitochondria ROS and disrupted mitophagy. Sirt3 deficiency inhibited the anti-viral innate immunity responses, increased viral loads and mitochondrial ROS production, disrupted mitophagy both in vivo and in vitro. Sirt3 knockdown replicated the cellular responses, while Sirt3 overexpression enhanced the antiviral innate immunity in microglia. Mechanism research revealed that HSV-1 infection disrupted CREB-mediated Sirt3 transcription. AMPK agonist metformin treatment could increase CREB-mediated Sirt3 transcription and enhance anti-viral innate immunity both in vitro and in vivo. In sum, our study reveals the inhibition of CREB-mediated Sirt3 transcription might be the pathology of HSV-1-induced neuropathic pain, which can be blocked by metformin.

Fields of Study & Subjects

Pain Mechanisms and Treatments Herpesvirus Infections and Treatments Sirtuins and Resveratrol in Medicine

Publication details

Journal / source
Cell Communication and Signaling
Volume
24
Issue
1
Publication date
28 March 2026
Language
EN